The Philippines’
major pharmaceutical importers and distributors, I.E. Medica, Inc. and MedEthix
Incorporated, were recently awarded three (3) major healthcare awards at
the Healthcare Asia Pharma Awards 2024 at Marina Bay Sands, Singapore.
The pharmaceutical
companies received the Supply Chain Initiative of the Year, Hospital
Partnership of the Year, and the Most Differentiated Service of the Year
awards. This marks the first time native Philippine pharmaceutical brands
have won in these categories. The brands are active proponents in the
importation, registration, and supply of healthcare products in the
Philippines.
I.E. Medica and
MedEthix executives, Monaliza Balnig Salian, co-founder, president and CEO, and
Ma. Victoria P. Sugapong, COO, accepted the awards on behalf of the pharma
group.
In her acceptance
speech, Monaliza B. Salian said, “The Philippine pharmaceutical industry is
heavily dependent on importation; thus, we continuously look for ways to
improve our supply chain operations. As a young pharma group, I.E. Medica and
MedEthix are aware of the overwhelming need of our countrymen for quality,
affordable, and accessible healthcare solutions—and so we will continue to
respond to these unmet needs, as Filipinos, for the Filipino.”
Salian’s acceptance
speech in the prestigious awards program is a fitting capstone to the young
local pharma group’s contribution to easing the burden of healthcare for
Filipinos. The awards conferred by the respected regional publication
Healthcare Asia magazine put I.E. Medica and MedEthix in the league of
outstanding pharma companies in Asia and the Pacific that have demonstrated an
unwavering commitment to innovation and excellence and have redefined
pharmaceutical excellence.
I.E. Medica:
Implementing enhanced end-to-end supply chain operations that could enhance the
nation’s healthcare product supply chain requirements
I.E. Medica is
driven to continuously improve its supply chain operations to comply with
Philippine Customs Administration import guidelines: from obtaining the Super
Green Lane certificate in 2017 to having demonstrated its initial compliance
with the cargo security risk management framework required for accreditation as
an Authorized Economic Operator (AEO) Importer.
The company is also
on track to securing the Level 1 AEO Certification, affirming its observance of
supply chain security standards and the benefits of improved accessibility to
healthcare goods brought about by streamlined import-export systems across borders,
ultimately benefiting Filipinos and earning it the Supply Chain Initiative of
the Year award.
MedEthix:
Introducing a game-changing COVID-19 treatment in the country
The impact of
COVID-19 has been widespread, with its magnitude affecting the stability of
social, economic, and political structures in many countries. It has
particularly challenged national healthcare systems and their capacity to
respond to large-scale outbreaks.
Filipino
pharmaceutical company MedEthix went beyond its way as the first importer to
secure its first four (4) hospital partners from the Food and Drug
Administration (FDA) and the compassionate special permit (CSP) for
Molnupiravir. This oral drug is indicated for mild to moderate cases of
COVID-19 infection, enabling the standard of care to go beyond the confines of
the overstretched hospital wards into the comforts of the patient’s home.
MedEthix further
expanded the distribution of Molnupiravir from the first 4 CSP grantees to over
80 health institutions and over 500 doctors across the country as soon as it
successfully secured the Emergency Use Authorization from the regulatory
authority. Healthway QualiMed, the hospital network of AC Health, played a
valuable role in its success. The hospital network, along with I.E. Medica and
MedEthix, are partners of AC Health. The expanded access to affordable
alternative treatment for COVID-19 greatly benefited Filipinos during the
pandemic and earned the company the Hospital Partnership and The Most
Differentiated Service of the Year awards.
A commitment to
every Filipino
As the recipients
of the three prestigious awards for the pharma category in the Philippines,
I.E. Medica and MedEthix remain committed to providing a wide range of products
that cover almost all therapeutic areas to meet the ever-changing healthcare
needs of Filipinos.
As the men and
women of I.E. Medica and MedEthix interact with doctors, retail outlets,
distributors, suppliers, regulatory authorities, and consumers daily, the
hallmark of excellence exemplified by the three awards continues to inspire
them to make a difference in the lives of their countrymen.
.jpg)
Post a Comment